Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Ulcerative Colitis Treatment Market To Reach $12.79 Billion By 2033 Biologics, Biosimilars & Small Molecules Rise. EINPresswire/ -- According to DataM Intelligence, the ulcerative colitis treatment ...

The update on this study could influence Pfizer’s stock performance positively, as successful results may enhance investor confidence in etrasimod’s market potential. In the competitive landscape of ...

Bacteria use multiple defense mechanisms to survive in the host body. Shigella bacteria that cause colitis disable multiple ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Study Overview: Pfizer Inc. is conducting a study titled ‘Evaluation of ...

The two main types of IBD are ulcerative colitis (UC) and Crohn's disease (CD). Do you or someone you love have moderate to ...

Cristcot's presence at ACG 2025 underscores its commitment to advancing evidence-based, patient-focused solutions that address persistent gaps in ulcerative colitis care. Additional information, ...

Crohn’s colitis is a type of Crohn’s disease that only affects the colon, or large intestine. It differs from other types of ...

In the realm of gastroenterology, inflammatory bowel disease (IBD), encompassing Crohn’s disease (CD) and ulcerative colitis (UC), presents a significant therapeutic challenge due to its chronic ...

People with inflammatory bowel disease, like ulcerative colitis, are 2 to 3 times more likely to develop blood clots than ...

A 29-year-old man undergoes a total proctocolectomy with end-to-end ileostomy after 2 years of surveillance for ulcerative colitis.

A cold front is expected to bring storms to Mississippi later this week after a period of quiet weather. The main threats from the system are damaging winds up to 60 mph and hail up to the size of ...